<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TEST" NEWID="15088" OLDID="4071" TOPICS="NO">
<DATE> 8-APR-1987 11:37:25.85</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f1482 reute
d f BC-MERCK-&lt;MRK&gt;-COMBINATI   04-08 0084</UNKNOWN>
<TEXT> 
<TITLE>MERCK &lt;MRK&gt; COMBINATION HEART DRUG AVAILABLE</TITLE>
<DATELINE>    NEW YORK, April 8 - </DATELINE><BODY>Merck and Co Inc said a combination
heart drug is available by prescription in the U.S.
    The drug is Vaseretic, a once-a-day medication combining an
angiotensin converting enzyme inhibitor (ACE) and a diuretic to
treat high blood pressure. The inhibitor is a new class of
antihypertensive drugs. Last year Merck introduced Vasotec, an
ACE inhibitor.
    The new drug combined Vasotec and HydroDiuril, a frequently
prescribed diuretic.
 Reuter
 </BODY></TEXT>
</REUTERS>